Greater China
China online education player Zhangmen targets US listing
Zhangmen, a private equity-backed Chinese online K-12 education platform specializing in one-to-one and small-class tuition, has filed for a US IPO.
Ocean Link, Sequoia seal China hotel operator take-private
Ocean Link and Sequoia Capital China have completed the $190 million privatization and subsequent delisting of Zhejiang New Century Hotel Management.
China chip IP specialist Akrostar raises $78m
Akrostar, a Chinese chip designer established less than a year ago by a team that spun out from US-headquartered industry leader Synopsys, has raised RMB500 million ($78 million) in Series A funding.
China-backed Oatly raises $1.4b in US IPO
Oatly, a Swedish oat-based, dairy-free beverage brand backed by a joint venture between China Resources Group and Verlinvest, raised $1.43 billion in its US IPO, facilitating partial exits for several investors.
Lilly Asia leads $90m round for China's Duality Biologics
Lilly Asia Ventures has led a $90 million Series B round for Duality Biologics, a Chinese developer of oncology and autoimmune drugs.
China's Meridian raises $330m for renminbi fund
Chinese VC firm Meridian Capital has closed its sixth renminbi-denominated fund at RMB2.12 billion ($330 million) after four months in the market.
Legend closes China healthcare continuation fund
Legend Capital has spun out the healthcare assets from two of its China venture capital funds into a continuation vehicle supported by Hamilton Lane and Coller Capital. The $270 million deal includes capital for follow-on investments.
Ikea entity leads Series C for China EV rental player
Dishangtie Car Rental, a Shenzhen-based electric vehicle (EV) rental service, has raised a $100 million Series C led by Ingka Holdings, a holding company for most of Ikea's stores.
China's Panacea, Dell family office raise $200m SPAC
Panacea Venture, a China-focused early-stage healthcare investor, has teamed up with Michael Dell’s family office to raise $200 million for a special purpose acquisition company (SPAC).
Q&A: Gaw Capital Partners' Christina Gaw
Hong Kong-based real estate investor Gaw Capital Partners has leveraged its knowledge and networks to expand into technology and education. Christina Gaw, a managing principal, explains how
China distress specialist DCL targets $466m fundraise
DCL Investments, one of China’s first private equity firms to focus on distressed assets, is looking to raise RMB3 billion ($466 million) for its latest renminbi-denominated fund.
China snack maker Weilong raises $549m, pursues HK IPO
China’s leading spicy snack food company Weilong has raised a $549 million pre-IPO round at a valuation of $9.4 billion and filed for a Hong Kong IPO.
Hong Kong NFT player raises $89m at $1b valuation
Hong Kong’s Animoca Brands, a blockchain-based games developer diversifying into non-fungible tokens (NFTs), has raised $88.9 million from a group of VCs at a valuation of $1 billion.
China HR SaaS player Beisen raises $260m
Beisen, China’s largest integrated human resources software-as-a-service (SaaS) platform, has raised $260 million in Series F funding. It is said to be the largest-ever round in this segment of enterprise services.
China's WeRide closes Series C, hits $3.3b valuation
Chinese autonomous driving company WeRide has achieved a valuation of $3 billion on closing a Series C round of undisclosed size. It comes four months after the company raised $310 million in Series B funding.
FountainVest leads Series B for China's MyMRO
Shanghai-based B2B e-commerce company MyMRO, a spinoff of US industrial products supplier Grainger, has raised several hundreds of million renminbi in Series B funding led by FountainVest Partners.
Vision Fund leads $330m investment in China grocery platform
Dingdong Macai, a China-based online fresh produce delivery business, has raised $330 million in an extended Series D round led by SoftBank Vision Fund.
China GPs commit $160m to local ADC player
DAC Biotech, a Chinese biotech company specializing in antibody-drug conjugates (ADCs) commonly used as targeted therapies for treating cancer, has raised RMB1 billion ($160 million) in Series C funding led by GL Ventures, CDG Capital, and CPE.
China self-driving truck start-up agrees $3.3b SPAC merger
Plus, a China-based autonomous driving technology developer that specializes in trucks, has agreed to merge with a special purpose acquisition company (SPAC) at a valuation of $3.3 billion.
Hong Kong crypto start-up gets $40m Series A
Sequoia Capital China, Tiger Global Management, and Boyu Capital have joined a $40 million Series A round for Hong Kong cryptocurrency services provider Babel Finance.
China medical tech supplier AMS raises $100m
China and US-based Access Medical Systems (AMS) has raised a $100 million round co-led by Sequoia Capital China and GL Ventures.
Portfolio: CDH Investments & China Grand Pharma
The contribution CDH Investments has made to China Grand Pharma belies the size of its equity interest in the company. M&A, at home and overseas, has been central to the growth strategy
Source Code leads Series C for China online insurance broker
Yuanbao, a Chinese online insurance broker, has raised nearly RMB1 billion ($156 million) in Series C funding led by Source Code Capital. Other investors include Cathay Capital, Hike Capital, Northern Light Venture Capital, Qiming Venture Partners, and...
China's Hope Medicine raises $56m Series B
Chinese innovative drug company Hope Medicine has raised a $56 million Series B round jointly led by Qiming Venture Partners and Grand Flight Investment.